[Use of trasylol as an inhibitor of proteases of the fibrinolysis system during extracorporeal circulation].
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D005112:Extracorporeal Circulation; D005340:Fibrinogen / Q000037:antagonists & inhibitors; D006801:Humans; D007430:Intraoperative Care; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011516:Prothrombin / Q000378:metabolism
D000933:Antifibrinolytic Agents; D011480:Protease Inhibitors; D011516:Prothrombin; D005340:Fibrinogen; D007611:Aprotinin
Zastosowanie trasylolu jako leku hamujacego proteazy układu fibrynolizy w krazeniu pozaustrojowym (ECC).